Skip to main content

Yaz and Yasmin Lawsuit News: Yaz and Yasmin MDL Convened for September Status Conference

By September 16, 2013November 1st, 2017Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_lawsuit_ocella_lawsuit_settlements_litigation_mdl_lawsuit_settlement_amounts_gallbladder_removal_disease_surgeryThe Yaz and Yasmin multidistrict litigation (MDL) convened for a status conference on September 4, 2013 in the U.S. District Court for the Southern District of Illinois. The court met to discuss updates to the Yaz and Yasmin lawsuits concerning venous thrombosis, or blood clots, and those lawsuits pertaining to arterial embolism.

According to court documents, both parties are currently working together to reach a resolution on the venous thrombosis cases.

The Yaz and Yasmin MDL is In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation MDL No. 2100. It is being heard by Chief Judge David R. Herndon.

The next Yaz and Yasmin MDL status conference has been scheduled for October 30.

Plaintiffs have filed Yaz and Yasmin lawsuits claiming that the contraceptive drugs caused serious harm and injury. The most commonly reported Yaz and Yasmin side effects include venous thrombosis, deep vein thrombosis, pulmonary embolism, heart attacks, and strokes.

According to a U.S. Food and Drug Administration (FDA) warning released in April 2012, data from studies demonstrate a link between the use of Yaz or Yasmin and blood clot formation, especially during the first six months of use. Also, both Yaz and Yasmin contain the hormone drospirenone, which has been associated with an increased risk of blood clot formation.

In a study published by the British Medical Journal in August 2009, researchers compared individuals not using a contraceptive drug to users of a drospirenone-containing contraceptive drug, like Yaz or Yasmin. They found that the risk of blood clot formation rose 6-fold in those using a contraceptive drug containing the hormone drospirenone.

From the evidence currently available, it appears that there is a strong link between venous thrombosis and the use of Yaz and Yasmin.

Carey Danis & Lowe Yaz and Yasmin lawyers represent women who claim to have been harmed by Yaz or Yasmin. Our experienced lawyers are currently accepting Yaz and Yasmin cases. We offer free legal consultations, as well as medical advice from our team of nurses.

We are here to help you achieve justice and resolution.

Contact Carey Danis & Lowe today by calling 800.721.2519, or by submitting a personal injury claim form.